votubia 3 mg
novartis pharma gmbh - germania - everolimus - compr. pt. disp. orala - 3mg - inhibitori de protein-kinaza inhibitor selectiv al mtor
votubia 5 mg
novartis pharma gmbh - germania - everolimus - compr. pt. disp. orala - 5mg - inhibitori de protein-kinaza inhibitor selectiv al mtor
kisplyx
eisai gmbh - lenvatinib mesilate - carcinomul, celula renală - agenți antineoplazici - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
funzol capsule 150 mg
bosnalijek, pharmaceutical and chemical industry jsc - fluconazolum - capsule - 150 mg
fluzon 150 150 mg comprimate filmate
cadila pharmaceuticals limited - fluconazolum - comprimate filmate - 150 mg
sandimmun neoral 100 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 100 mg
sandimmun neoral 25 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 25 mg
sandimmun neoral 50 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 50 mg
ivemend pulbere pentru solutie perfuzabila 150 mg
schering-plough central east ag - fosaprepitantum - pulbere pentru solutie perfuzabila - 150 mg
tegretol comprimate 200 mg
novartis pharma ag - carbamazepinum - comprimate - 200 mg